Quick Answer
PSYENCE BIOMEDICAL LTD. reported Research And Development Expense of $342.2 thousand for the year ending 2025.
- PSYENCE BIOMEDICAL LTD. showed a decrease of -64.2% in Research And Development Expense from 2024 to 2025.
- This data is from PSYENCE BIOMEDICAL LTD.'s annual report (Form 10-K), filed with the SEC on June 25, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), PSYENCE BIOMEDICAL LTD.'s Research And Development Expense has declined by 78.7%.
- Historical annual values: Fiscal year 2025: $342.2 thousand | Fiscal year 2024: $954.6 thousand | Fiscal year 2023: $1.61 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: